Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals and Torii Pharmaceutical Expand Collaboration to Combat Common Warts in Global Phase 3 Trial

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced this week an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Ltd. This collaboration marks a critical step …

Verrica Pharmaceuticals and Torii Pharmaceutical Expand Collaboration to Combat Common Warts in Global Phase 3 Trial Read More

InterDigital

InterDigital Inks Patent License Agreement with Samsung, Bolstering its Position in Consumer Electronics

WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC), a heavyweight in the mobile and video technology industry, has announced a new patent licensing agreement with global electronics giant Samsung. This strategic …

InterDigital Inks Patent License Agreement with Samsung, Bolstering its Position in Consumer Electronics Read More
Venatorx Pharmaceuticals

Venatorx Pharmaceuticals Strikes Deal with Menarini Group for Global Rights to Cefepime-Taniborbactam

MALVERN, PA — Venatorx Pharmaceuticals recently granted exclusive commercial rights to Italy’s Menarini Group for its novel antibiotic, cefepime-taniborbactam. The agreement extends to 96 countries in Europe, Latin America, Middle …

Venatorx Pharmaceuticals Strikes Deal with Menarini Group for Global Rights to Cefepime-Taniborbactam Read More

InterDigital

InterDigital and Panasonic Renew Patent Licenses: A Strategic Move in the Entertainment and Communication Space

WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC) has announced the renewal of its patent license agreements with Panasonic Entertainment & Communication Co., Ltd. This move not only extends Panasonic’s license …

InterDigital and Panasonic Renew Patent Licenses: A Strategic Move in the Entertainment and Communication Space Read More